Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Mesothelioma × budigalimab × 1 year × Clear all

Sponsor

Conditions

Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Squamous Cell Carcinoma of Head and Neck 5 Triple Negative Breast Neoplasms 3 Carcinoma, Hepatocellular 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Melanoma 1 Esophageal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Neuroendocrine 1 Anophthalmia with pulmonary hypoplasia 1

Interventions

pembrolizumab 11 Nivolumab 8 Cisplatin 7 Pemetrexed 6 Carboplatin 6 Ipilimumab 5 Cyclophosphamide 5 fludarabine 4 durvalumab 4 tremelimumab 2 tocilizumab 1 tislelizumab 1 tazemetostat 1 sargramostim 1 osimertinib 1 olaparib 1 obinutuzumab 1 niraparib 1 naptumomab estafenatox 1 fludarabine phosphate 1 decitabine and cedazuridine drug combination 1 bintrafusp alfa protein, human 1 Tumor Burden 1 Thoracoscopy 1 Temozolomide 1 Tablets 1 Saline Solution 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Quality of Life 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡